R&G PHARMASTUDIES CO., LTD.

Highlights R&G PharmaStudies Co., Ltd.

Equities

301333

CNE100005K44

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
44.49 ^CNY	+1.58%		+1.02%	-31.00%

21/04	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	21/04	CI
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	29/23/29	CI
R&G Pharmastudies Co., Ltd. Implements Final Cash Dividend on A Shares for 2022, Payable on 29 June 2023	21/23/21	CI
R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022	02/23/02	CI
R&G Pharmastudies Co., Ltd. Proposes Cash Final Dividend for 2022	26/23/26	CI
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24/23/24	CI
R&G PharmaStudies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26/22/26	CI
R&G PharmaStudies Co., Ltd. has completed an IPO in the amount of CNY 1.1832 billion.	26/22/26	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer